Cargando…
Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
Autores principales: | Solodky, M.L., Galvez, C., Russias, B., Detourbet, P., N’Guyen-Bonin, V., Herr, A.-L., Zrounba, P., Blay, J.-Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of European Society for Medical Oncology.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/ https://www.ncbi.nlm.nih.gov/pubmed/32360743 http://dx.doi.org/10.1016/j.annonc.2020.04.475 |
Ejemplares similares
-
Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
por: Heudel, Pierre, et al.
Publicado: (2022) -
Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients
por: Heudel, P., et al.
Publicado: (2021) -
Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study
por: Assaad, Souad, et al.
Publicado: (2021) -
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
por: Assaad, Souad, et al.
Publicado: (2020) -
Photoplethysmographic determination of the respiratory rate in acutely ill patients: validation of a new algorithm and implementation into a biomedical device
por: L’Her, Erwan, et al.
Publicado: (2019)